Toggle main navigation
News
Insights
Meetings
Multimedia
ASCO AI in Oncology
Search
Close
AI in Oncology
Bladder Cancer
Breast Cancer
Cardio-oncology
CNS Cancers
Colorectal Cancer
Cost of Care
Infectious Diseases
Gastrointestinal Cancer
Genomics/Genetics
Geriatric Oncology
Global Cancer Care
Gynecologic Cancers
Head and Neck Cancer
Health-Care Policy
Hepatobiliary Cancer
Immunotherapy
Kidney Cancer
Leukemia
Lung Cancer
Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes
Neuroendocrine Tumors
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
Survivorship
Thyroid Cancer
Solid Tumors
Hematologic Malignancies
Issues in Oncology
News
Announcements
From the Journals
FDA Update
Direct From ASCO
Advertisement
Gynecologic Cancers
Risovalisib Yields Highest Reported Monotherapy Response Rate in Ovarian Clear Cell Carcinoma
November 18
2 min read
In a phase II trial, risovalisib yielded a 35% objective response rate in patients with recurrent or persistent
PIK3CA
-mutated ovarian clear cell carcinoma.
CNS Cancers
A ‘Split’ Decision: Fractionated vs Single-Fraction Radiosurgery After Brain Metastasis Resection
November 18
8 min read
Leukemia
Report Outlines ‘Evolutionary Dynamics’ in the Years Before AML Diagnosis
November 18
5 min read
Breast Cancer
I-SPY2.2: RT-DXd May Reduce Chemotherapy Exposure in Immune-Positive Early Breast Cancer
November 17
3 min read
Pancreatic Cancer
Adding SBRT to Chemotherapy Reduces Locoregional Recurrence in High-Risk Pancreatic Cancer
November 17
3 min read
Breast Cancer
FDA Approves Giredestrant Plus Everolimus for
ESR1
-Mutant Advanced Breast Cancer
November 17
3 min read
Breast Cancer
Chemotherapy for Breast Cancer Linked to Accelerated Biological Aging
November 17
4 min read
Latest in News
Load More
Advertisement